February 6, 2017
Portola nets $150M deal with HealthCare Royalty Partners
Portola Pharmaceuticals has signed a $150 million royalty deal with HealthCare Royalty Partners (HCR).
Pharmaceuticals, Biotechnology and Life Sciences
Tag: andexanet alfa